Back to Browse Journals » Pharmacogenomics and Personalized Medicine » Volume 5

Pharmacogenomic considerations in opioid analgesia

Authors Vuilleumier PH, Stamer UM, Landau R

Received 27 February 2012

Accepted for publication 16 April 2012

Published 23 August 2012 Volume 2012:5 Pages 73—87


Review by Single-blind

Peer reviewer comments 2

Pascal H Vuilleumier,1 Ulrike M Stamer,1 Ruth Landau2

1Klinik für Anästhesiologie und Schmerztherapie, Inselspital Universität Bern, Switzerland; 2Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA

Abstract: Translating pharmacogenetics to clinical practice has been particularly challenging in the context of pain, due to the complexity of this multifaceted phenotype and the overall subjective nature of pain perception and response to analgesia. Overall, numerous genes involved with the pharmacokinetics and dynamics of opioids response are candidate genes in the context of opioid analgesia. The clinical relevance of CYP2D6 genotyping to predict analgesic outcomes is still relatively unknown; the two extremes in CYP2D6 genotype (ultrarapid and poor metabolism) seem to predict pain response and/or adverse effects. Overall, the level of evidence linking genetic variability (CYP2D6 and CYP3A4) to oxycodone response and phenotype (altered biotransformation of oxycodone into oxymorphone and overall clearance of oxycodone and oxymorphone) is strong; however, there has been no randomized clinical trial on the benefits of genetic testing prior to oxycodone therapy. On the other hand, predicting the analgesic response to morphine based on pharmacogenetic testing is more complex; though there was hope that simple genetic testing would allow tailoring morphine doses to provide optimal analgesia, this is unlikely to occur. A variety of polymorphisms clearly influence pain perception and behavior in response to pain. However, the response to analgesics also differs depending on the pain modality and the potential for repeated noxious stimuli, the opioid prescribed, and even its route of administration.

Keywords: pain perception, opioid analgesia, genetic variation, pharmacogenetics

Corrigendum for this paper has been published

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Pharmacogenomic considerations in opioid analgesia. [Corrigendum]

Vuilleumier PH, Stamer UM, Landau R

Pharmacogenomics and Personalized Medicine 2013, 6:1-2

Published Date: 14 January 2013

Readers of this article also read:

Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface

Montanaro J, Inic-Kanada A, Ladurner A, Stein E, Belij S, Bintner N, Schlacher S, Schuerer N, Mayr UB, Lubitz W, Leisch N, Barisani-Asenbauer T

Drug Design, Development and Therapy 2015, 9:3741-3754

Published Date: 21 July 2015

Family caregivers’ role implementation at different stages of dementia

Huang HL, Shyu YIL, Chen MC, Huang CC, Kuo HC, Chen ST, Hsu WC

Clinical Interventions in Aging 2015, 10:135-146

Published Date: 5 January 2015

Novel nano-rough polymers for cartilage tissue engineering

Balasundaram G, Storey DM, Webster TJ

International Journal of Nanomedicine 2014, 9:1845-1853

Published Date: 15 April 2014

Novel glutamatergic drugs for the treatment of mood disorders

Lapidus KAB, Soleimani L, Murrough JW

Neuropsychiatric Disease and Treatment 2013, 9:1101-1112

Published Date: 7 August 2013

Extended-release hydrocodone – gift or curse?

Krashin D, Murinova N, Trescot AM

Journal of Pain Research 2013, 6:53-57

Published Date: 10 January 2013

To use or not to use: an update on licit and illicit ketamine use

Jih-Heng Li, Balasingam Vicknasingam, Yuet-wah Cheung, et al

Substance Abuse and Rehabilitation 2011, 2:11-20

Published Date: 16 March 2011

Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)-paclitaxel nanoconjugate

Sang Van, Sanjib K Das, Xinghe Wang, et al

International Journal of Nanomedicine 2010, 5:825-837

Published Date: 11 October 2010